Table 1 Demographic and Clinical Characteristics of the study population
PMN (n = 41) | LN-V (n = 19) | DN (n = 28) | p-value | Total (n = 88) | |
|---|---|---|---|---|---|
Age (years) | 44.5 ± 17.5 | 33.8 ± 13.9 | 46.8 ± 14.2 | 0.02 | 42.9 ± 16.4 |
Female gender [n (%)] | 25 (61.0) | 17 (89.5) | 18 (64.3) | 0.07 | 60 (68.2) |
Race (Black) [n (%)] | 13 (31.7) | 7 (36.8) | 9 (32.1) | 0.92 | 29 (32.9) |
mABP (mmHg) | 94.6 ± 11.7 | 85.7 ± 8.0 | 99.4 ± 16.1 | 0.01 | 94.3 ± 13.4 |
Presence of oedema [n (%)] | 26 (89.7) | 8 (53.3) | 16 (64.0) | 0.02 | 50 (72.5) |
Hb (g/dL) | 11.8 ± 2.1 | 10.6 ± 2.3 | 9.9 ± 1.7 | 0.001 | 11.0 ± 2.2 |
Platelet count (x109/L) | 368.4 ± 129.2 | 307.4 ± 149.4 | 340.9 ± 137.1 | 0.34 | 348.3 ± 135.7 |
WBC count (x109/L) | 8.4 ± 2.4 | 8.5 ± 4.6 | 9.0 ± 3.2 | 0.76 | 8.6 ± 3.1 |
Total cholesterol (mmol/L) | 9.3 (7.8–11.6) | 4.6 (3.7–5.8) | 6.3 (4.8–7.9) | 0.001 | 7.8 (5.5–9.6) |
Serum albumin (g/L) | 21.8 ± 7.1 | 25.4 ± 7.4 | 28.0 ± 5.9 | 0.004 | 24.3 ± 7.3 |
UPCR (g/mmol creatinine) | 0.87 (0.49–1.26) | 0.54 (0.27–0.75) | 0.52 (0.17–1.34) | 0.07 | 0.72 (0.34–1.24) |
Serum creatinine (µmol/L) | 80 (63–103) | 72 (51–123) | 188 (97–471) | 0.001 | 96 (66–167) |
eGFR (mL/min/1.73 m2) | 85 (57–124) | 98 (49–137) | 30 911 − 63) | 0.001 | 68 (38–111) |